These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

207 related items for PubMed ID: 28375568

  • 1. Fludrocortisone therapy for persistent hyperkalaemia.
    Dobbin SJH, Petrie JR, Lean MEJ, McKay GA.
    Diabet Med; 2017 Jul; 34(7):1005-1008. PubMed ID: 28375568
    [Abstract] [Full Text] [Related]

  • 2. Fludrocortisone Is an Effective Treatment for Hyperkalaemic Metabolic Acidosis in Kidney Transplant Recipients on Tacrolimus: A Case Series.
    Gama RM, Makanjuola D, Wahba M, Quan V, Phanish M.
    Nephron; 2022 Jul; 146(2):190-196. PubMed ID: 34784594
    [Abstract] [Full Text] [Related]

  • 3. Severe hyperkalemic type 4 renal tubular acidosis after kidney transplantation: a case report.
    Rangel EB, Gomes SA, Machado PG, dos Santos BF, Pestana JO, Pacheco-Silva A, Heilberg IP.
    Transplant Proc; 2006 Nov; 38(9):3112-5. PubMed ID: 17112912
    [Abstract] [Full Text] [Related]

  • 4. Amelioration of metabolic acidosis with fludrocortisone therapy in hyporeninemic hypoaldosteronism.
    Sebastian A, Schambelan M, Lindenfeld S, Morris RC.
    N Engl J Med; 1977 Sep 15; 297(11):576-83. PubMed ID: 18672
    [Abstract] [Full Text] [Related]

  • 5. Amelioration of hyperchloremic acidosis with furosemide therapy in patients with chronic renal insufficiency and type 4 renal tubular acidosis.
    Sebastian A, Schambelan M, Sutton JM.
    Am J Nephrol; 1984 Sep 15; 4(5):287-300. PubMed ID: 6524600
    [Abstract] [Full Text] [Related]

  • 6. Effect of fludrocortisone acetate on reducing serum potassium levels in patients with end-stage renal disease undergoing haemodialysis.
    Kim DM, Chung JH, Yoon SH, Kim HL.
    Nephrol Dial Transplant; 2007 Nov 15; 22(11):3273-6. PubMed ID: 17616536
    [Abstract] [Full Text] [Related]

  • 7. [Arterial hypertension with hyperkalemia, tubular acidosis and normal renal function: Gordon syndrome and/or pseudohypoaldosteronism type II?].
    Ader JL, Waeber B, Suc JM, Brunner HR, Tran-Van T, Durand D, Praddaude F.
    Arch Mal Coeur Vaiss; 1988 Jun 15; 81 Spec No():193-7. PubMed ID: 2973296
    [Abstract] [Full Text] [Related]

  • 8. Fludrocortisone-a treatment for tubulopathy post-paediatric renal transplantation: A national paediatric nephrology unit experience.
    Ali SR, Shaheen I, Young D, Ramage I, Maxwell H, Hughes DA, Athavale D, Shaikh MG.
    Pediatr Transplant; 2018 Mar 15; 22(2):. PubMed ID: 29345400
    [Abstract] [Full Text] [Related]

  • 9. Renal tubular acidosis type IV in hyperkalaemic patients--a fairy tale or reality?
    Haas CS, Pohlenz I, Lindner U, Muck PM, Arand J, Suefke S, Lehnert H.
    Clin Endocrinol (Oxf); 2013 May 15; 78(5):706-11. PubMed ID: 22891694
    [Abstract] [Full Text] [Related]

  • 10. Alport's syndrome with type 4 renal tubular acidosis.
    McDonnell T, Chukwu C, Wong C.
    BMJ Case Rep; 2017 May 31; 2017():. PubMed ID: 28566416
    [Abstract] [Full Text] [Related]

  • 11. Incidence of hyperkalemic RTA in pediatric post-renal transplant patients and the role of fludrocortisone.
    Alabdulqader MA, Azzam A, Alshami AA.
    Pediatr Transplant; 2021 Sep 31; 25(6):e14029. PubMed ID: 34021680
    [Abstract] [Full Text] [Related]

  • 12. Pseudohypoaldosteronism type II: proximal renal tubular acidosis and dDAVP-sensitive renal hyperkalemia.
    Nahum H, Paillard M, Prigent A, Leviel F, Bichara M, Gardin JP, Idatte JM.
    Am J Nephrol; 1986 Sep 31; 6(4):253-62. PubMed ID: 3777034
    [Abstract] [Full Text] [Related]

  • 13. [Type IV renal tubular acidosis: pathogenetic role of aldosterone deficiency and hyperkalemia].
    Schambelan M, Sebastian A.
    Nephrologie; 1985 Sep 31; 6(3):135-7. PubMed ID: 3908957
    [Abstract] [Full Text] [Related]

  • 14. Fludrocortisone is effective in the management of tacrolimus-induced hyperkalemia in liver transplant recipients.
    Dick TB, Raines AA, Stinson JB, Collingridge DS, Harmston GE.
    Transplant Proc; 2011 Sep 31; 43(7):2664-8. PubMed ID: 21911143
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Primary role of hyperkalemia in the acidosis of hyporeninemic hypoaldosteronism.
    Matsuda O, Nonoguchi H, Tomita K, Shiigai T, Ida T, Shinohara S, Ideura T, Takeuchi J.
    Nephron; 1988 Sep 31; 49(3):203-9. PubMed ID: 3398981
    [Abstract] [Full Text] [Related]

  • 17. Type 4 renal tubular acidosis in a kidney transplant recipient.
    Kulkarni M.
    Biomed J; 2016 Feb 31; 39(1):85-6. PubMed ID: 27105603
    [Abstract] [Full Text] [Related]

  • 18. Control of hyperkalemia with fludrocortisone in a patient with systemic lupus erythematosus.
    Dreyling KW, Wanner C, Schollmeyer P.
    Clin Nephrol; 1990 Apr 31; 33(4):179-83. PubMed ID: 2350905
    [Abstract] [Full Text] [Related]

  • 19. [Renal tubular acidosis (type 2) in a Friesian mare].
    van der Kolk JH.
    Tijdschr Diergeneeskd; 1994 Nov 15; 119(22):675-6. PubMed ID: 7974459
    [Abstract] [Full Text] [Related]

  • 20. Furosemide/Fludrocortisone Test and Clinical Parameters to Diagnose Incomplete Distal Renal Tubular Acidosis in Kidney Stone Formers.
    Dhayat NA, Gradwell MW, Pathare G, Anderegg M, Schneider L, Luethi D, Mattmann C, Moe OW, Vogt B, Fuster DG.
    Clin J Am Soc Nephrol; 2017 Sep 07; 12(9):1507-1517. PubMed ID: 28775126
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.